ArticleFrontiers in immunology2026
HBV pgRNA induces chronic inflammation in an IL-1β-dependent manner.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic hepatitis B (CHB) is a widespread form of hepatitis B infection with advanced complications if unsupervised and untreated. It was previously reported that pregenomic RNA (pgRNA) can be detected in blood circulation as an indirect marker of HBV transcriptional activity. The aim of this study was to investigate the transcriptomic profile of pgRNA-positive patients with CHB in comparison to pgRNA-negative patients and to evaluate its role in innate immunity. Materials and methods: A total of 88 patients with CHB who were receiving nucleoside analogs (NAs) were enrolled in this study. The viral load and genotype, HBV pgRNA, and biochemical and virological markers were determined. Samples from eight CHB HBeAg-negative patients were sequenced. Four of them were positive for HBV pgRNA, while the rest were negative. These data were processed via bioinformatic tools. Bioinformatic analyses revealed common pathways such as platelet activation and neutrophil degranulation, for which experimental setups were organized. Platelet activation, as well as platelet-neutrophil interactions, was examined. Furthermore, the synthesis and expression of interleukins IL-1β, IL-17A, and LL-37 were studied. Results: The percentage of patients positive for HBV pgRNA in the study population was 18.1%. With respect to the transcriptomic analysis, which was performed via two distinct analyses, we identified common differentially expressed (DE) genes involved in platelet activation and neutrophil degranulation pathways. Afterwards, the induction of autophagy in platelets and the Conclusions: This study demonstrated that HBV pgRNA activates platelets in an autophagy-dependent manner. Moreover, the platelet-neutrophil axis is responsible for a proinflammatory phenotype in which IL-1β is overexpressed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.